18F-Dasatinib

N/A

Report date: 2025/11/28 15:16:08
NME

Base Information

Drug Name18F-Dasatinib
Drug Alias Name18F-SKI-249380[18F]-Fluoro-BMS-354825[18F]Dasatinib[18F]SKI-249380[18F]Fluoro-BMS-354825
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionTyrosine-protein kinase FYN inhibitorsTyrosine-protein kinase SRC inhibitorsBcr-Abl tyrosine kinase inhibitors +[8] 
TargetsTyrosine-protein kinase FYNTyrosine-protein kinase SRCBcr-Abl tyrosine kinase +[8] 
Therapy Area/IndicationsDiagnostic agentsBone Marrow NeoplasmsCarcinoma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesMemorial Sloan Kettering Cancer Center
Inactive CompaniesN/A
Active IndicationsDiagnostic agentsNeoplasms
Inactive IndicationsBone Marrow NeoplasmsCarcinomaMelanoma +[5] 

Other Information

ATC CodeN/A
Related LinksN/A